Sigrid Therapeutics AB
Sweden
- Stockholm
- 20/01/2023
- Unknown
- $580,679
Lifestyle diseases, caused by poor diet and physical inactivity among others, are rising worldwide. Each year 70% of all deaths globally – 40 million – are attributed to lifestyle diseases such as obesity, type 2 diabetes and heart disease.
Sigrid is a clinical-stage biotech company driven by the vision to improve human health through material-based innovations. We are pioneering a new class of engineered materials to prevent and treat lifestyle disease more safely and effectively.
- Industry Medical Equipment Manufacturing
- Website https://www.sigridthx.com/
- LinkedIn https://www.linkedin.com/company/sigrid-therapeutics-ab/
Related People
Sana AlajmovicCo Founder
Sweden -
Greater Stockholm Metropolitan Area
Entrepreneur with a demonstrated history of working in the biotechnology industry. Skilled in Business Planning, Operations Management, Sales, Entrepreneurship, and International Business. Strong business development professional with a BSc Program in Business and Economcis focused in Economics and Marketing from Stockholm School of Economics.
catalyx space | $5,400,000 | (Nov 4, 2025)
mimic(SWITZERLAND) | $160,000,000 | (Nov 4, 2025)
xMEMS | $21,000,000 | (Nov 4, 2025)
Zeeg | $1,265,935 | (Nov 4, 2025)
Cephia AI | $4,000,000 | (Nov 4, 2025)
Ornn | $5,700,000 | (Nov 4, 2025)
octonomy | $20,000,000 | (Nov 4, 2025)
Helex | $3,500,000 | (Nov 4, 2025)
Hullbot | $16,000,000 | (Nov 4, 2025)
Indomo | $25,000,000 | (Nov 4, 2025)
AUI™ (Augmented Intelligence) | $20,000,000 | (Nov 4, 2025)
Popai Health | $11,000,000 | (Nov 4, 2025)